Insurance Carriers and Related Activities (U.S.) — Subsector Primer

NAICS 2022 code 524. This is a rollup: it combines two child industry groups — 5241 Insurance Carriers and 5242 Agencies, Brokerages, and Other Insurance Related Activities — into one 3-digit subsector. NAICS is the North American Industry Classification System, the U.S. federal standard for grouping businesses. Figures for this level are our ingested federal ground truth (U.S. Census Bureau [1]). Premium, claims, and market-share figures come from insurance regulators and trade sources cited in the child primers [2][3]; they use different scopes and accounting than Census data.

---

1. Overview

NAICS 524 is essentially the entire private U.S. insurance economy in one code — everyone who makes an insurance policy, and almost everyone who sells, services, prices, or settles one. It sits under NAICS 52 "Finance and Insurance," alongside banking (522) and securities/investment (523), and it splits cleanly along the single question that organizes the whole business: who bears the risk?

• 5241 — Insurance Carriers: the manufacturers. Every company that actually underwrites — takes the premium, holds the reserves, invests the money in between ("float"), and pays the claim — whether it covers a person (life, health, annuities), property and liability (auto, home, commercial, title), or another insurer (reinsurance) [2].
• 5242 — Agencies, Brokerages, and Other Insurance Related Activities: the intermediaries. Everyone who works around the policy for a fee but never puts their own balance sheet behind it — agents and brokers who sell it, pharmacy-benefit managers and third-party administrators who run the back office, adjusters who settle the loss, and actuaries and data firms who price and grade the risk [3].

That one cleavage — risk-bearer versus fee-earner — drives every difference that follows, and it is the reason to read 524 as its own thing. The carriers are few, huge, capital-heavy, cyclical, and regulated for solvency; the intermediaries are many, small, capital-light, more stable, and regulated for conduct. They are two halves of the same value chain with opposite economics.

At scale, this is one of the largest industries in the country: about $3.27 trillion in annual receipts, roughly 2.96 million employees, 176,459 establishments, and 135,425 firms [1]. Both public-market and private investors can participate — but the two children offer fundamentally different bets (bear the risk, or collect the toll), and in both an unusually large slice of the industry cannot be bought as stock at all.

---

2. What's inside — the two child industry groups and how they differ

The single most useful orienting fact: the carriers hold the dollars, the intermediaries are the crowd. About 4,644 carrier firms — just 3% of the subsector's firms — earn ~85% of its receipts, while 131,043 intermediary firms (97% of the firms, 84% of the establishments) split the remaining ~15%. Jobs, by contrast, divide almost evenly (~56% carriers / ~44% intermediaries) [1][2][3]. So "insurance" as a money-handler is overwhelmingly the manufacturers; "insurance" as an employer and as a Main Street presence is half the salesforce.

How the economics genuinely diverge:

• Who puts capital behind the promise. A carrier's whole business is standing behind a future claim it cannot yet size — so it must hold reserves, statutory capital, and enough surplus to survive a worst-case year, and it earns on both an underwriting margin and the investment income from float [2]. An intermediary touches none of that: it earns a commission or fee and gets paid regardless of which carrier wins the customer or whether that carrier has a good year [3]. This is why 5241 is capital-intensive and cyclical while 5242 is capital-light and comparatively steady — and why a broker can earn through a loss year the carrier eats.
• The dollars, the bodies, and the storefronts point different ways. By receipts the split is ~85/15 toward carriers; by jobs it is nearly even; by establishments and firm count it inverts to ~84/16 and ~97/3 toward intermediaries. No single share describes the subsector — you have to say which yardstick.
• They rise and fall on the same cycle, with very different risk. A broker's commission is a percentage of the carrier's premium, so when property-and-casualty (P&C) prices harden, both children's revenues climb together; when the market softens — as it is now — both feel it [2][3]. Same swing factor, but the carrier absorbs the actual losses and the intermediary does not. That linkage is the tightest thread binding the two halves.
• The health giants are re-stitching the boundary NAICS draws. The federal code splits manufacturing (5241) from services (5242), but the largest health conglomerates straddle both: UnitedHealth owns a health carrier and Optum Rx (a pharmacy-benefit manager, a 5242 activity); CVS Health owns Aetna and Caremark; Cigna owns a carrier and Express Scripts. Vertical integration is deliberately capturing manufacturing and services in one company to own the whole "healthcare dollar" [2][3].

A note on the boundary. Government insurance programs and backstops sit outside this subsector entirely — Medicare and Medicaid as public payers, the FDIC and NCUA as deposit insurers, and the federal flood and crop programs are classified in public administration, not 524. Only private, risk-bearing carriers (5241) and private intermediaries (5242) are inside. So 524 is "the private insurance economy," not "all insurance."

---

3. How big it is (this level's rollup)

Federal ground-truth figures for the whole subsector (NAICS 524):

(The children reconcile cleanly to the level. Employment sums line-for-line — 1,653,582 + 1,310,504 = 2,964,086 — as do establishments — 28,557 + 147,902 = 176,459 [1][2][3]. Receipts ($2,774B + $495B ≈ $3,270B) and payroll ($177.2B + $115.2B ≈ $292.3B) reconcile within rounding. Firm counts sum to 135,687 versus the level's 135,425 — a tiny (~262-firm) overlap, because a group operating as both a carrier and an intermediary is counted in each child but only once at the level. That internal consistency is a good sign the federal file measures the same universe at both tiers.)

Concentration reads as "highly competitive" — but that is a mirage, and a doubly deceptive one. The level HHI of 193.1 and CR4 of 21.7% sit far below the 1,000–1,500 line antitrust agencies treat as "unconcentrated" (HHI is the sum of squared market shares on a 0–10,000 scale). Two things hide behind that low number:

1. The level number is dragged toward the carriers. Because 5241 is ~85% of receipts, the blended HHI (193.1) sits right next to the carriers' own HHI (190.7) and far below the intermediaries' (548.8) [1][2][3]. Pooling two very different structures into one $3.27 trillion base produces a figure that describes neither child.
2. Even each child's number understates the concentration a real buyer faces. The national statistic averages away the truth: health coverage is bought in state and metro markets where one or two carriers routinely hold 50–70% share; U.S. title insurance is a four-firm oligopoly (~85% of premium); global reinsurance has its top ten holding ~59%; and three pharmacy-benefit managers process ~80% of U.S. prescriptions [2][3]. Treat 193.1 as a floor for the aggregate, not a description of any market anyone actually shops in.

Undercount and scope caveats — read before quoting:

1. Receipts are distorted in both directions at once — never treat $3.27 trillion as clean "insurance value." On the carrier side, the figure is a 2022 receipts flow that understates the industry: it is not premiums written and not the balance sheet (P&C direct premiums alone ran ~$1.1 trillion; U.S. life carriers sit on a ~$9.3 trillion asset base flow figures never touch; much reinsurance covering U.S. risk is written cross-border and never registers as domestic receipts) [2]. On the intermediary side, the figure is inflated: most of 5242's receipts are drug costs flowing through pharmacy-benefit managers on their way to pharmacies — money the manager never keeps — while brokers' receipts are the commission they keep, not the trillions of premium that pass through them [3]. The dollar total is a distorted proxy; the reliable signals are the structural facts (two businesses, their headcounts, their concentration shapes).
2. The undercount is asymmetric — it lives on the intermediary side. County Business Patterns counts only establishments with paid employees and excludes the self-employed [3]. Many single-agent brokerages, captive agents, and solo public adjusters operate as sole proprietors, so the true population of people working in insurance distribution is meaningfully higher than counted — a classic small-operator undercount in 5242. The carrier side (5241) has almost the opposite problem: a licensed carrier requires capital, filings, and paid staff, so few real carriers are missed.
3. A large bloc is well-counted but not investable — in both children. This is not the "missing tiny operator" problem. The huge mutual, reciprocal, and nonprofit carriers (State Farm, Liberty Mutual, USAA, Northwestern Mutual, New York Life, MassMutual, the Blue Cross Blue Shield federation, Kaiser) are fully captured — they have employees and file with regulators — but have no public stock [2]. So does the vast private-equity-backed brokerage and claims-administration tier in 5242 [3]. Much of the largest tonnage on both sides never appears in a brokerage account.
4. No aggregate underwriting metrics. The federal file reports no premiums, claims, reserves, surplus, combined ratios, medical loss ratios, or investment income for this level; those come from regulators and trade sources cited in the child primers. The SBA small-business size standard also differs by activity (for example, an employee threshold for P&C carriers versus a receipts threshold for brokerages and title), so there is no single small-business line for the subsector [2].

(A derived "receipts per employee" of ~$1.10 million is not a productivity measure here — it blends carrier premium flow with pharmacy pass-through, so it is left uninterpreted.)

---

4. The investable universe — where value concentrates across the children

Value in 524 concentrates in the carriers by dollars, but the cleanest, highest-quality public exposure to the idea of insurance-without-catastrophe sits in the intermediaries — and in both children a large slice of the industry is unbuyable as equity. Tickers below refer to a parent holding company, not a single carrier or agency legal entity, and consolidated revenue often spans more than one insurance code — reserve the names and figures for this section and Section 10.

Carriers (5241) — the dollars, split public and unbuyable across five lines. Public exposure runs by line of business:

• Life & annuity: a dozen-plus mid-cap carriers (MetLife (MET), Prudential (PRU), Principal (PFG), Corebridge (CRBG), Equitable (EQH), Lincoln (LNC)), valued on price-to-book value and yield; an indirect route is owning the asset-manager parents (Apollo (APO), KKR (KKR)) that run the fast-growing Athene and Global Atlantic annuity engines [2].
• Health: a concentrated large-cap cluster — UnitedHealth (UNH), CVS Health/Aetna (CVS), Cigna (CI), Elevance (ELV), Centene (CNC), Humana (HUM), Molina (MOH) — valued on normalized earnings (their reported revenue overstates pure-insurance size because it includes owned PBMs and care delivery) [2].
• P&C: carriers by exposure — Progressive (PGR), Allstate (ALL), Chubb (CB), Travelers (TRV), The Hartford (HIG), W. R. Berkley (WRB) — plus the conglomerate Berkshire Hathaway (BRK.B, which owns GEICO) [2].
• Title: a rare near-pure-play cluster — Fidelity National Financial (FNF), First American (FAF), Old Republic (ORI), Stewart (STC) [2].
• Reinsurance: a handful of specialists — Everest (EG), RenaissanceRe (RNR), Arch Capital (ACGL), Reinsurance Group of America (RGA) — plus European majors (Munich Re, Swiss Re) on foreign exchanges [2].

The big carrier slice you can't buy: the mutuals, reciprocals, and nonprofits above are among the very largest firms in the country; households participate only as policyholders [2].

Intermediaries (5242) — the cleanest public bet on the group's core idea. The distribution layer offers capital-light, recurring commission revenue with no underwriting risk — the purest "insurance without hurricanes" exposure in the whole subsector. Value sits at two poles:

• Listed brokers: Marsh McLennan (MMC), Aon (AON), Arthur J. Gallagher (AJG), Brown & Brown (BRO), Willis Towers Watson (WTW), plus specialty/digital names (Ryan Specialty (RYAN), Goosehead (GSHD)) [3].
• The services corner (52429): there is no pure-play PBM — its economics live inside the health giants above; the cleanest listed economics belong to the data/advisory franchise Verisk Analytics (VRSK), with insurance-software names (CCC Intelligent Solutions (CCCS), Guidewire (GWRE)); claims adjusting has essentially one listed pure-play, Crawford & Company (CRD-A/CRD-B) [3].

The big intermediary slice you can't buy: most of the industry and most of the growth are private — the PE-backed roll-up platforms (Acrisure, Hub International, USI, Alliant, Lockton), the largest claims administrator (PE-owned Sedgwick), and employee-owned advisers (Milliman) [3].

The through-line: in both children the stock market shows only part of the picture — carriers hide a mutual/nonprofit/PE bloc, intermediaries hide a PE-roll-up bloc. There is no dedicated exchange-traded fund (ETF) for the subsector or either child; broad insurance, financials, and health-care funds hold these names only in small weights. Map the legal entities and segment economics before valuing any name on consolidated revenue.

---

5. How the money works

The two children run on two different profit models, and telling them apart is the whole analytical discipline of the subsector.

Carriers (5241): underwriting margin + investment income on float. Every carrier collects premium up front, holds reserves for claims not yet paid, invests the money in between, and pays claims and expenses later — keeping two sets of books (conservative statutory accounting filed with regulators, which gates dividends, and GAAP for investors), both constrained by risk-based capital (RBC) rules. But the loss economics differ sharply by line: a life carrier earns mostly an investment spread on a huge long-duration float (industry net investment yield ~4.4% in 2024); a health carrier earns a thin spread on this year's medical costs, with its margin legally floored by the Affordable Care Act's medical-loss-ratio rule; a P&C carrier earns an underwriting margin (the combined ratio — claims plus expenses ÷ premiums earned; below 100% is a profit — ran ~96.9% industry-wide in 2024) plus float; a title carrier prevents the loss and lives on its expense ratio; a reinsurer does the same math wholesale on another insurer's book [2].

Intermediaries (5242): fees and commissions for a service — no float. Absent everywhere here: premiums earned, the combined ratio, reserves, investment float. Present everywhere: labor, data, technology, and client-retention economics. Brokers earn a slice of the premium that passes through them (base commission renewing each year, fees on large accounts, volatile contingent commissions) and are judged on organic growth, client/producer retention (90%+ at the best books), EBITDA margin (~25–30%+, where EBITDA is earnings before interest, taxes, depreciation, and amortization), and roll-up multiple arbitrage. The services corner runs three meters: claims adjusting (fee-per-claim, labor-heavy), third-party administrators (recurring per-member-per-month fees, software-like), and PBMs (thin per-script margins on colossal drug volume, with reported revenue mixing pass-through cost and true service fee); the highest-quality economics sit in data/advisory (recurring subscriptions, near-zero marginal cost) [3].

The one discipline that spans both children. For a carrier, analyze the regulated insurance subsidiaries — statutory surplus, RBC, reserve adequacy — not just the parent's consolidated income statement. For an intermediary, separate true service/commission revenue from the money merely flowing through — the premium a broker places, the drug cost a PBM passes on, the claim an adjuster disburses. Both traps come down to the same thing: do not confuse money that touches the balance sheet with money the business keeps. How owners get paid also splits by structure: for-profit carriers and brokers return cash via dividends and buybacks (carriers valued on book/earnings, brokers on recurring-fee multiples), while mutuals and nonprofits pay no outside dividend — a mutual's "return" is its participating-policy dividend; a nonprofit reinvests surplus [2][3].

---

6. What drives demand

Because the subsector is ~85% carriers by receipts, its aggregate dollar demand tracks the carriers — but the intermediaries move on the same signals one step removed, and one demographic fact runs through much of it: America is aging (the 65-and-over population reached ~61 million in 2024, and roughly one in five Americans will be of retirement age by 2030), which converts steadily into annuity buyers and Medicare beneficiaries [2].

• Premium volume = rate × exposure. This is the master switch for both children at once. When insurance prices harden or insured activity grows (more payroll, property, vehicles, revenue), carrier premiums rise and broker commissions — a percentage of those premiums — rise with them. Structural tailwinds (cyber, artificial-intelligence liability, "social inflation" from rising jury verdicts, climate risk pushing business into specialty markets) lift both [2][3].
• Retirement and interest rates (life). Record retail annuity sales (~$434 billion in 2024), pension-risk-transfer, and a large protection gap, all swung by the rate path [2].
• Health and drug spend. The shift into Medicare Advantage, employer coverage, and rising medical costs (~$5.3 trillion of national health spending) drive the carriers; U.S. prescription-drug spending (~$467 billion in 2024, up ~8%) and employer self-funding drive the PBM/administrator core of 5242 [2][3].
• Catastrophe activity. Hurricanes, wildfires, and storms swing P&C carriers and claims adjusters — the most volatile demand line in the subsector — with ~$100+ billion of U.S. insured catastrophe losses in recent years [2][3].
• Mortgage rates (title) and consumer spending ("other"). Title volume freezes and thaws with rates; warranty, pet, and device protection ride durable-goods sales [2].

Two forces cut across the whole level: inflation (a demand tailwind that raises the value of coverage but a margin headwind that raises claims — medical, repair, wage, construction) and artificial intelligence (a cost lever in underwriting, claims, and title search that also lifts data-moated advisers while trimming labor hours per routine claim) [2][3].

---

7. Regulation

Both children share one spine: state regulation. Under the McCarran-Ferguson Act of 1945, "the business of insurance" is left to the states, coordinated (not overridden) by the National Association of Insurance Commissioners (NAIC). There is no federal insurance regulator; the Treasury's Federal Insurance Office monitors but does not set rates or solvency [2][3].

But the kind and intensity of oversight split sharply along the risk-bearing line:

• Carriers are regulated for solvency. Because they hold the public's money and stand behind future claims, carriers face statutory accounting, risk-based capital with escalating intervention if capital falls too low, reserve-adequacy review, and state guaranty funds that backstop policyholders if a carrier fails. Federal overlays attach by line: the SEC and FINRA govern variable-annuity disclosure (life); CMS sets Medicare Advantage and Part D rates and the medical-loss-ratio rule (health); RESPA's anti-kickback rules govern title; and "credit for reinsurance" rules govern reinsurance [2].
• Intermediaries are regulated for conduct — a lighter, pro-scale barrier, with one glaring exception. Agents and brokers must be licensed in each state, meet continuing-education rules, and follow sales-conduct standards — a moderate barrier that favors scaled platforms but does not cap prices or returns [3]. The exception is the services corner: pharmacy-benefit managers face the fiercest regulatory assault in the entire subsector — the Federal Trade Commission (FTC) found the top three process ~80% of U.S. prescriptions and sued them over insulin rebates, all 50 states have passed PBM laws since 2017, and "delinking" (barring PBM pay from a drug's price) is spreading [3].

The cross-cutting live theme reaches into both children at once: asset-intensive life-and-annuity reinsurance ceded offshore (mostly to Bermuda), where the NAIC and the Financial Stability Oversight Council are scrutinizing capital, asset quality, and disclosure — a single regulatory story that spans the life carriers of 5241 and the reinsurers within it, and the broader shift of insurance capital toward asset managers [2].

---

8. Consolidation

Both children are consolidating hard, by different mechanisms — and both keep a large bloc structurally off-limits.

• Carriers (5241): an unacquirable core anchors the child — mutuals, reciprocals, and nonprofit Blues/Kaiser are owned by policyholders or communities and will not be rolled up in the ordinary way. Around it, alternative-asset managers pair permanent insurance capital with in-house credit to out-bid traditional carriers on annuity pricing (Apollo/Athene, KKR/Global Atlantic), often via reinsurance and block transactions; and health verticalizes (UnitedHealth/Optum, CVS/Caremark) to capture the whole healthcare dollar [2].
• Intermediaries (5242): one force dominates — private-equity roll-up. PE-backed consolidators buy agencies at ~690–700 deals a year with PE involved in ~70% of transactions, and 2025 brought the two largest brokerage deals in history (Gallagher–AssuredPartners at ~$13.45 billion; Brown & Brown–Accession at ~$9.8 billion). PBM/TPA consolidation runs through vertical integration into insurers and PE-owned platforms (Carlyle's Sedgwick) [3].

The common thread across the whole subsector: scale, capital, and data are decisive everywhere, yet a huge bloc — mutual/nonprofit carriers on one side, and the deep tail of small independents on the other — resists acquisition, so the marginal deal migrates to the capital-light layers (distribution, administration, data) and to the capital markets (catastrophe bonds and other insurance-linked securities reached ~$136 billion by end-2025). And despite record deal-making, the sheer depth of 135,000 firms keeps the subsector's headline concentration low [1][2][3].

---

9. Risks

Risks cluster by child, but the recurring pattern is that the carrier bears loss and capital risk, the intermediary bears cycle, leverage, and regulatory risk — with several exposures spanning both:

• Pricing-cycle risk (both children). The single tightest linkage: today's near-record P&C margins are cyclical, prices are softening (the first broad soft market in ~9 years), and this cuts carrier underwriting profit and the premium-linked broker commissions at the same time [2][3].
• Catastrophe and climate risk (P&C carriers + claims adjusting). A bad hurricane, wildfire, or storm cluster can erase a carrier's year and swings adjuster demand violently [2][3].
• Interest-rate / asset-liability risk (life, reinsurance). A duration mismatch turns rate moves into losses, heightened for asset-intensive reinsurers reaching for yield in private credit [2].
• Medical-cost trend and government dependence (health). Utilization running ahead of locked-in premiums compresses margins fast, and a single CMS rate change hits the top line faster than carriers can reprice [2].
• PBM regulatory/model risk (services, 5242). Delinking, rebate-pass-through mandates, and FTC enforcement are the biggest single threat to the intermediaries' largest profit pool — and to the subsector's headline receipts [3].
• Leverage and rich acquisition prices (5242). The PE-owned roll-ups carry acquisition debt sensitive to interest rates and integration risk [3].
• Offshore/affiliated-reinsurance opacity (life, reinsurance). Ceding annuity blocks to captive Bermuda affiliates can weaken the policyholder backstop while the original carrier still owes the benefit [2].
• Ownership, disclosure, and liquidity risk (both children). The large mutual, nonprofit, and private-equity bloc has strong franchises but limited disclosure and no ordinary exit route.
• Cyber and data risk (all). Carriers and administrators hold vast troves of personal, medical, and financial data — a breach is material-to-existential [2][3].
• Measurement / classification risk (analyst-level). As Section 3 shows, the $3.27 trillion receipts total is distorted in both directions and the blended HHI describes no real market — anchoring on either will mis-scale the subsector [1].

---

10. How to invest & outlook

The subsector is two fundamentally different bets, not one. Because 524 splits along the risk-bearing line, an investor should first choose which side of the promise they want to own:

Bet 1 — Bear the risk (carriers, 5241). Cyclical, capital-intensive, valued on book value and normalized earnings, paying out via dividends and buybacks. Choose the line whose master variable you want — life (MET, PRU, PFG, CRBG, EQH, LNC; or the asset-manager parents APO/KKR), health (UNH, ELV, CVS, CI, HUM, CNC, MOH), P&C (PGR, ALL, CB, TRV, HIG, WRB; Berkshire BRK.B; or ETFs KIE, IAK), title (FNF, FAF, ORI, STC), reinsurance (EG, RNR, ACGL, RGA) — and diligence the regulated subsidiaries: statutory surplus, RBC, reserve development, catastrophe load versus pricing [2].

Bet 2 — Collect the toll (intermediaries, 5242). Capital-light, recurring, less cyclical, valued on premium multiples of recurring fee revenue — the higher-quality compounders of the subsector. The clean picks-and-shovels play is the listed brokers (MMC, AON, AJG, BRO, WTW; specialty RYAN, GSHD), judged on organic growth, retention, producer economics, and acquisition discipline. The largest reported profits (PBM) are reachable only through diversified health giants (UNH, CI, CVS) and squarely in the regulatory crosshairs; the most durable economics belong to the data franchises (VRSK, CCCS, GWRE) [3].

Own the whole chain. A few vehicles straddle both children: Berkshire Hathaway (carriers + reinsurance) and the health giants (a carrier fused to a PBM). There is no level-wide ETF; broad financials, insurance, and health-care funds hold slices of each side.

Private and institutional routes. A pattern recurs across both children: you often can't buy the best operators, so buy the plumbing. Households reach the life mutuals and annuity platforms as policyholders; institutions back sponsor-driven annuity/reinsurance platforms and the PE-backed brokerage and claims roll-ups, lend private credit to the consolidators, and — uniquely on the carrier/reinsurance side — put capital directly behind the risk through insurance-linked securities (catastrophe bonds, sidecars, collateralized reinsurance) that pay returns largely uncorrelated with stocks and can lose principal after a defined event [2][3].

Outlook (forward-looking judgment, not fact). The two children face opposite near-term swing factors on the same cycle: the softening insurance market pressures carrier P&C margins and broker commissions together, while the structural tailwinds diverge — the aging population converts durably into annuity buyers and Medicare members (carriers), and drug spend plus employer self-funding keeps feeding the services layer (intermediaries), even as PBM regulation looms as the single biggest policy swing. The cleanest way to read the subsector is that the carriers are the cyclical, capital-heavy value/book plays, and the intermediaries are the capital-light, recurring-fee compounders — two halves of one value chain that the health giants are busy stitching back together. Net: a structurally growing, cash-generative subsector whose two children run on the same premium cycle but opposite risk profiles, so the sharpest way to own NAICS 524 is to decide first whether you want to bear the risk or collect the toll — and then size the line-of-business exposures deliberately rather than treat "insurance" as one thing.

---

Sources

Synthesized from the two child primers (5241, 5242) and our ground-truth federal stats extract for NAICS 524; citation numbers are this primer's own.

1. U.S. Census Bureau. 2022 Economic Census — Concentration of Largest Firms and County Business Patterns 2023, NAICS 524 (receipts, firms, establishments, employment, payroll, CR4/CR8/CR20/CR50, HHI). Histometrics ingested federal ground-truth stats. https://data.census.gov/; https://www.census.gov/programs-surveys/cbp.html
2. Histometrics child primer — NAICS 5241 Insurance Carriers (and its underlying NAIC, CMS, LIMRA, KFF, AM Best, ALTA, Swiss Re, SBA sources; children 52411 life/health, 52412 P&C/title/other, 52413 reinsurance).
3. Histometrics child primer — NAICS 5242 Agencies, Brokerages, and Other Insurance Related Activities (and its underlying FTC, MarshBerry, Verisk/SEC, CMS, BLS, NAIC sources; children 52421 agencies & brokerages, 52429 other insurance related activities).
4. National Association of Insurance Commissioners (NAIC). U.S. Life & A&H and Property/Casualty Industry Results (~$9.3T life assets, ~4.4% net investment yield; P&C 96.9% combined ratio, ~$1.13T surplus). 2025. https://content.naic.org/
5. Centers for Medicare & Medicaid Services. National Health Expenditure Fact Sheet (~$5.3T total health spending; ~$467B prescription-drug spending, up ~8%). 2026. https://www.cms.gov/data-research/statistics-trends-and-reports/national-health-expenditure-data/nhe-fact-sheet
6. AM Best. 2025 U.S. Property/Casualty Premiums (~$1.11 trillion direct premiums) and World's Largest Reinsurers (top-10 ~59% of global premium). 2026. https://news.ambest.com/
7. LIMRA. 2024 Retail Annuity Sales Reach a Record $434.1 Billion. 2025. https://www.limra.com/
8. American Land Title Association (ALTA). Title Insurance Premium Volume and Market Share (Big Four ~85%). 2026. https://www.alta.org/
9. U.S. Federal Trade Commission. Interim Staff Report on Prescription Drug Middlemen (top three PBMs process ~80% of U.S. prescriptions); PBM enforcement and state "delinking" laws. 2024–2026. https://www.ftc.gov/
10. MarshBerry / Insurance Journal. Insurance-agency M&A (~690–700 deals/yr, ~70% PE participation; Gallagher–AssuredPartners ~$13.45B; Brown & Brown–Accession ~$9.8B). 2025–2026. https://www.marshberry.com/
11. Verisk Analytics / U.S. SEC. Advisory and insurance-data economics. 2026. https://www.sec.gov/cgi-bin/browse-edgar
12. Aon. Alternative Capital Reaches Record High (insurance-linked securities ~$136 billion, end-2025). 2025–2026. https://aon.mediaroom.com/